Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Change in Taxes (2017 - 2020)

Historic Change in Taxes for Avalo Therapeutics (AVTX) over the last 4 years, with Q2 2020 value amounting to $839000.0.

  • Avalo Therapeutics' Change in Taxes rose 29873.23% to $839000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $839000.0, marking a year-over-year increase of 14625.19%. This contributed to the annual value of $288000.0 for FY2020, which is 11945.17% up from last year.
  • Per Avalo Therapeutics' latest filing, its Change in Taxes stood at $839000.0 for Q2 2020, which was up 29873.23% from -$551000.0 recorded in Q1 2020.
  • Avalo Therapeutics' Change in Taxes' 5-year high stood at $3.2 million during Q3 2017, with a 5-year trough of -$970852.0 in Q4 2017.
  • Its 4-year average for Change in Taxes is $69972.6, with a median of -$190199.0 in 2018.
  • Per our database at Business Quant, Avalo Therapeutics' Change in Taxes plummeted by 304064.86% in 2019 and then soared by 29873.23% in 2020.
  • Quarter analysis of 4 years shows Avalo Therapeutics' Change in Taxes stood at -$970852.0 in 2017, then surged by 83.23% to -$162790.0 in 2018, then crashed by 184.28% to -$462783.0 in 2019, then soared by 281.29% to $839000.0 in 2020.
  • Its Change in Taxes stands at $839000.0 for Q2 2020, versus -$551000.0 for Q1 2020 and -$462783.0 for Q4 2019.